VOYA Investment Management’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Buy
8,205
+444
+6% +$14.6K ﹤0.01% 1998
2025
Q4
$246K Buy
+7,761
New +$233K ﹤0.01% 2067
2025
Q3
Sell
-11,283
Closed -$128K 2634
2025
Q2
$128K Buy
+11,283
New +$107K ﹤0.01% 2428
2025
Q1
Sell
-11,100
Closed -$122K 2724
2024
Q4
$122K Sell
11,100
-740
-6% -$9.09K ﹤0.01% 2530
2024
Q3
$146K Sell
11,840
-92
-0.8% -$1.3K ﹤0.01% 2568
2024
Q2
$161K Buy
+11,932
New +$161K ﹤0.01% 2543
2024
Q1
Sell
-11,175
Closed -$58.8K 2878
2023
Q4
$58.8K Hold
11,175
﹤0.01% 2834
2023
Q3
$44K Hold
11,175
﹤0.01% 2866
2023
Q2
$119K Buy
+11,175
New +$119K ﹤0.01% 2740
2022
Q1
Sell
-82,407
Closed -$1.98M 2747
2021
Q4
$1.98M Sell
82,407
-472
-0.6% -$11.3K ﹤0.01% 1161
2021
Q3
$2.11M Sell
82,879
-4,477
-5% -$125K ﹤0.01% 1149
2021
Q2
$2.94M Buy
87,356
+29,092
+50% +$1.03M 0.01% 1042
2021
Q1
$2.26M Sell
58,264
-8,649
-13% -$492K ﹤0.01% 1127
2020
Q4
$4.14M Sell
66,913
-70,103
-51% -$3.21M 0.01% 870
2020
Q3
$4.59M Sell
137,016
-6,889
-5% -$197K 0.01% 778
2020
Q2
$3.43M Buy
+143,905
New +$3.42M 0.01% 868

Other funds holding STOK

VOYA Investment Management's STOK Position: Q1 2026 in Review

VOYA Investment Management increased its Stoke Therapeutics (STOK) stake by 5.7% in Q1 2026, buying an estimated $14.6K and bringing the position to 8,205 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #1998.

VOYA Investment Management first reported a position in STOK in Q2 2020 and has held it in 16 quarters since. The position peaked at $4.59M in Q3 2020. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • VOYA Investment Management held 8,205 shares of Stoke Therapeutics worth $267K as of Q1 2026.
  • VOYA Investment Management bought 444 Stoke Therapeutics shares in Q1 2026, an estimated $14.6K.
  • Stoke Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1998 holding.
  • VOYA Investment Management first reported a position in Stoke Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • VOYA Investment Management's Stoke Therapeutics position peaked at $4.59M in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.